-Noriko Hatakeyama Researcher Activity Profile

Research Author Detailed Information 

Noriko Hatakeyama Publication Rate By Year

Noriko Hatakeyama has published 1 paper(s) in 2005, 9 paper(s) in 2007, 3 paper(s) in 2008, for a total of 13 research publications in total.

Noriko N Hatakeyama Author Information

LAST NAME: hatakeyama

FIRST NAME: Noriko

INITIALS: n

AFFILIATION:

Papers

Noriko Hatakeyama's Publication Record

1. [Evaluation on the effect of dosimetry using a depth of calibration point or a depth of temporary dose maximum in high energy electron beams.] Year Published: 2005
Department of Clinical Radiology, Hiroshima International University, 555-36, Gakuendai, Kurosecho, Higashihiroshima-shi, Hiroshima, 724-0695, Japan. k-haneda@hs.hirokoku-u.ac.jp.
2. Enhancement of cytoprotective ability and cell restoration in 70-kDa heat shock protein gene-transfected rat gastric mucosal cells. Year Published: 2007
Department of Internal Medicine-1, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan.
3. Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Year Published: 2007
Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
4. Involvement of glucocorticoid receptor and pregnane X receptor in the regulation of mouse CYP3A44 female-predominant expression by glucocorticoid hormone. Year Published: 2007
Department of Toxicology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, Japan.
5. Carbamazepine-induced hemolytic and aplastic crises associated with reduced glutathione peroxidase activity of erythrocytes. Year Published: 2007
Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan.
6. Involvement of glucocorticoid receptor and pregnane X receptor in the regulation of mouse CYP3A44 female-predominant expression by glucocorticoid hormone. Year Published: 2007
Department of Toxicology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, Japan.
7. A significant improvement in lower limb pain after treatment with alendronate in two cases of Camurati-Engelmann disease. Year Published: 2007
Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, South-1, West-16, Chuo-ku, Sapporo, 060-8543, Japan, iba@sapmed.ac.jp.
8. Carbamazepine-induced hemolytic and aplastic crises associated with reduced glutathione peroxidase activity of erythrocytes. Year Published: 2007
Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan. ymasaki@sapmed.ac.jp
9. A significant improvement in lower limb pain after treatment with alendronate in two cases of Camurati-Engelmann disease. Year Published: 2007
Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, South-1, West-16, Chuo-ku, Sapporo 060-8543, Japan. iba@sapmed.ac.jp
10. Vascular endothelial dysfunction in septic shock. Year Published: 2008
11. [Vascular endothelial dysfunction in septic shock] Year Published: 2008
nmatsuda@kuhp.kyoto-u.ac.jp
12. Large Brunner's gland hyperplasia treated with modified endoscopic submucosal dissection. Year Published: 2007
Department of Gastroenterology, Akita University School of Medicine, 1-1-1, Hondo, Akita City, Akita 010-8543, Japan. reina@doc.med.akita-u.ac.jp
13. An autopsy case of rapid progressive atypical carcinoid of the lung discovered with multiple nodular shadows. Year Published: 2008
Departments of Respiratory Medicine, National Hospital Organization, Kochi Hospital, Kochi, Japan.